Israeli company wins €2.5M to combat drug resistance
The company's immune-based protein signature MeMed BV distinguishes between bacterial and viral infections, helping physicians determine whether antibiotic treatment is appropriate.
EXPERTS CLAIM uncontrolled antibiotic use is turning farmed animals into reservoirs of drug-resistant bacteria that can easily spread. (photo credit: DREAMSTIME/TNS)ByLEON SVERDLOV
